Metastatic renal cell carcinoma

Metastatic renal cell carcinoma (mRCC) ke mofuta oa mofetše oa liphio o hasaneng likarolong tse ling tsa 'mele. Likhetho tsa kalafo li fapana ho latela sethala le litšobotsi tse ikhethang tsa mofetše, empa hangata li kenyelletsa kalafo e lebisitsoeng, immunotherapy, opereishene le kalafo ea radiation. Ho lemoha kapele le maano a macha a kalafo a bohlokoa bakeng sa ho ntlafatsa sephetho ho bakuli ba nang le mRCC. Tataiso ena e fana ka tlhaloso e tebileng ea mRCC, e akaretsa lisosa tsa eona, matšoao, tlhahlobo, mekhoa ea phekolo, le prognosis.What is Renal Cell Carcinoma and Metastasis?Renal cell carcinoma (RCC) ke mofuta o tloaelehileng haholo oa kankere ea liphio ho batho ba baholo. E tsoa lera la proximal convoluted tubule, li-tubes tse nyenyane haholo ka har'a liphio tse hloekisang mali le ho tlosa litšila. Ha RCC e metastasize, e bolela hore lisele tsa mofetše li khaohile ho tloha hlahala ea pele ea liphio 'me li hasana likarolong tse ling tsa' mele, tse kang matšoafo, masapo, boko kapa sebete. Ha e se e nametse, e hlalosoa e le Metastatic renal cell carcinoma (mRCC).Lisosa le Lintho tsa Kotsi tsa Renal Cell CarcinomaSesosa se tobileng sa RCC hase kamehla se hlakileng, empa lintlha tse 'maloa li ka eketsa kotsi ea ho tšoaroa ke lefu lena: Ho Tsuba: Batho ba tsubang ba kotsing e kholo ea ho tšoaroa ke RCC ha ho bapisoa le batho ba sa tsubeng. Botenya: Ho ba boima bo feteletseng kapa botenya ho amahanngoa le kotsi e eketsehileng. Khatello e Phahameng ea Mali: Khatello e phahameng ea mali e sa foleng e ka senya liphio le ho eketsa kotsi ea mofetše. Nalane ea Lelapa: Ho ba le nalane ea lelapa ea RCC ho eketsa kotsi ea hau. Maemo a mang a futsitsoeng, a kang lefu la von Hippel-Lindau (VHL), lefu la Birt-Hogg-Dube, le lefutso la papillary renal cell carcinoma, a amahanngoa le kotsi e kholo. Boloetse bo tsoetseng pele ba liphio kapa Dialysis: Batho ba nang le lefu la liphio le sa foleng, haholo-holo ba nang le dialysis, ba na le kotsi e eketsehileng. Ho Hlahisa Lik'hemik'hale Tse Ling: Ho pepeseha mosebetsing ho cadmium, trichlorethylene, le likokoana-hloko tse ling li 'nile tsa amahanngoa le RCC.Symptoms of Metastatic Renal Cell Carcinoma Mehato ea pele ea RCC hangata ha e na matšoao. Ha hlahala e ntse e hōla kapa e fetoha metastasize, matšoao a ka 'na a bonahala. Tsena li ka fapana ho latela hore na mofetše o nametse hokae, empa matšoao a tloaelehileng a Metastatic renal cell carcinoma kenyeletsa: Mali ka har'a moroto (hematuria) Bohloko bo sa khaotseng ka lehlakoreng kapa mokokotlong Leqeba kapa boima ka lehlakoreng kapa mokokotlong Ho lahleheloa ke boima ho sa hlalosoang Mokhathala Feberu e sa bakoeng ke tšoaetso Khaello ea mali (palo e tlaase ea lisele tse khubelu tsa mali) Bohloko ba masapo (haeba kankere e nametse masapong) Ho ruruha maqaqailaneng le maotong Ho hlahlojoa ha Metastatic Renal Cell Metastatic renal cell carcinoma hangata e kenyelletsa tlhahlobo ea tlhahlobo ea 'mele, liteko tsa litšoantšo, le li-biopsies. Tlhahlobo ea 'Mele: Ngaka e tla etsa tlhahlobo ea' mele ho hlahloba hore na ho na le lintho tse sa tloaelehang. Liteko tsa ho Etsa Litšoantšo: CT Scan: CT scan e fana ka litšoantšo tse qaqileng tsa liphio le lisele tse potolohileng 'me e ka thusa ho lemoha lihlahala le ho hlahloba boholo ba tsona le sebaka sa tsona. MRI: MRI e ka fana ka litšoantšo tse qaqileng haholoanyane 'me hangata e sebelisetsoa ho lekola boholo ba mofetše. Bone Scan: Ho sebelisoa tlhahlobo ea masapo ho hlahloba hore na mofetše o nametse masapong. PET Scan: Ho hlahloba PET ho ka thusa ho lemoha lisele tsa mofetše ’meleng kaofela. Biopsy: Biopsy e kenyelletsa ho tlosa sampole e nyane ea liphio kapa sebaka sa metastatic bakeng sa tlhahlobo ka tlas'a microscope. Sena se tiisa tlhahlobo ea RCC mme se thusa ho fumana mofuta o itseng oa RCC.Treatment Options for Metastatic Renal Cell CarcinomaTreatment for Metastatic renal cell carcinoma ho itšetlehile ka lintlha tse ’maloa, tse akarelletsang boholo ba kankere, bophelo bo botle ba mokuli ka kakaretso le litšobotsi tse khethehileng tsa hlahala. Likhetho tse tloaelehileng tsa kalafo li kenyelletsa:Targeted TherapyTargeted therapy litlhare li shebile limolek'hule tse itseng tse amehang kholong ea lisele tsa mofetše le ho phela. Lithethefatsi tsena li ka thusa ho fokotsa kholo ea mofetše le ho ntlafatsa maemo a bophelo. Dikalafo tse tlwaelehileng tse lebisitsweng bakeng sa mRCC li kenyeletsa: VEGF inhibitors (mohlala, sunitinib, sorafenib, pazopanib, axitinib, cabozantinib): Lithethefatsi tsena li thibela tsela ea vascular endothelial growth factor (VEGF), e leng ea bohlokoa bakeng sa ho thehoa ha methapo ea mali ka har'a lihlahala. mTOR inhibitors (mohlala, everolimus, temsirolimus): Lithethefatsi tsena li thibela sepheo sa mammalian sa tsela ea rapamycin (mTOR), e amehang khōlong ea lisele le metabolism.Lithethefatsi tsa ImmunotherapyImmunotherapy li thusa sesole sa' mele ho lemoha le ho hlasela lisele tsa kankere. Lithethefatsi tsena li bonts'itse litholoana tse ts'episang ho alafa mRCC. Li-immunotherapies tse tloaelehileng bakeng sa mRCC li kenyelletsa: Checkpoint inhibitors (mohlala, nivolumab, pembrolizumab, ipilimumab): Lithethefatsi tsena li thibela liprotheine ka lisele tsa 'mele tse thibelang ho hlasela lisele tsa mofetše.Ho buuoa ho buuoa e ka ba khetho ea ho tlosa liphio (nephrectomy) kapa ho tlosa lihlahala tsa metastatic likarolong tse ling tsa' mele. Sena se ka thusa ho imolla matšoao le ho ntlafatsa boleng ba bophelo. Cytoreductive nephrectomy e akarelletsa ho tlosa hlahala e ka sehloohong ea liphio esita le haeba kankere e nametse likarolong tse ling tsa 'mele. Sena se ka ntlafatsa katleho ea liphekolo tse ling.Kalafo ea RadiationRadiation e sebelisa maballo a matla a phahameng ho bolaea lisele tsa mofetše. E ka sebelisoa ho kokobetsa bohloko kapa matšoao a mang a bakoang ke lihlahala tsa metastatic, haholo-holo masapong kapa bokong. Bakuli ba nang le Metastatic renal cell carcinoma e ka 'na ea nahana ho kenya letsoho tekong ea kliniki ea ho fumana mekhoa ea phekolo ea morao-rao.Prognosis of Metastatic Renal Cell CarcinomaThe prognosis for Metastatic renal cell carcinoma e fapana ho itšetlehile ka lintlha tse ’maloa, tse akarelletsang boholo ba kankere, bophelo ba mokuli ka kakaretso le tsela eo a arabelang ka eona phekolong. Ho latela nalane, mRCC e ne e na le bofokoli bo bobe, empa tsoelo-pele ea kalafo e lebisitsoeng le immunotherapy e ntlafalitse haholo liphetho ho bakuli ba bangata. Lintlha tse ka susumetsang bonohe li kenyeletsa International Metastatic Renal Cell Carcinoma Database Database Consortium (IMDC) risk score, e nahanang ka lintlha tse kang nako ea ho hlahlojoa ho fihlela kalafo, boemo ba ts'ebetso, maemo a hemoglobin, maemo a calcium, neutrophil count, le platelet count.Ho phela le Metastatic Renal Cell CarcinomaHo phela le Metastatic renal cell carcinoma e ka ba phephetso, ’meleng le maikutlong. Ho bohlokoa ho ba le ts'ehetso e matla le ho nka mehato ea ho laola matšoao le litla-morao tsa kalafo. Sena se ka kenyelletsa: Taolo ea bohloko Tšehetso ea phepo e nepahetseng Boikoetliso le phekolo ea 'mele Ho fana ka keletso kapa lihlopha tsa tšehetso Karolo ea Shandong Baofa Cancer Research InstituteAt. Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa, re ikemiselitse ho fana ka tlhokomelo e phethahetseng le e ncha ea mofetše. Re ikemiselitse ho ntšetsa pele lipatlisiso tsa mofetše le ho fa bakuli liphekolo tse ntle ka ho fetisisa. Sehlopha sa rona sa li-oncologists tse nang le boiphihlelo, lingaka tse buoang, le basebetsi ba ts'ehetso ba sebetsa 'moho ho theha merero ea kalafo ea mokuli e mong le e mong ba tsepamisitse maikutlo ho ntlafatseng bophelo le ho phela ka kakaretso. Re ikitlaelletsa ho fana ka likhatelopele tsa morao-rao kalafong ea mofetše, ho kenyeletsoa liphekolo tse lebisitsoeng, immunotherapies, le liteko tsa bongaka.Future Directions in Metastatic Renal Cell Carcinoma Research Research ka Metastatic renal cell carcinoma e ntse e tsoela pele, ka sepheo sa ho hlahisa liphekolo tse ncha le tse sebetsang haholoanyane. Libaka tsa morao-rao tsa lipatlisiso li kenyelletsa: Ho hlahisa mekhoa e mecha ea phekolo le li-immunotherapies Ho tsebahatsa li-biomarker tse ka bolelang esale pele karabelo ea phekolo Ho utloisisa mekhoa ea ho hanyetsa phekolo e lebisitsoeng le immunotherapy Ho hlahisa mekhoa e mecha ea ho thibela ho ata ha RCBy ho tsoela pele ho ntlafatsa kutloisiso ea rona ea mRCC, re ka ntlafatsa liphello tsa bakuli ba nang le lefu lena le thata.